Shaw Prize Honors APL Leukaemia Research Team

Hong Kong's Shaw Prize ceremony recognised three scientists for work that greatly reduced acute promyelocytic leukaemia mortality.

Updated on Nov. 10, 2026 in Awards

Clean laboratory bench with rows of amber-filled glass vials and a pipette on a steel tray, with soft window light and a blurred city skyline beyond.
Hong Kong's Shaw Prize honored French and Chinese scientists Anne Dejean, Hugues de The, and Zhu Chen on November 10, 2026, for pioneering a targeted therapy that greatly reduced acute promyelocytic leukaemia deaths. AI Illustration. Upload story photo >

The 2026 Shaw Prize in Life Science and Medicine was presented at the Hong Kong Convention and Exhibition Centre to Anne Dejean, Hugues de The, and Zhu Chen. The laureates were recognised for discovering the molecular and cellular bases of acute promyelocytic leukaemia (APL) and pioneering a synergistic, targeted therapy.

Why it matters

The award highlights a therapy that greatly reduced APL mortality and an East-meets-West research collaboration. Its recognition underscores how sustained international cooperation can produce major advances in cancer treatment.

Each Shaw Prize consists of a medal, a certificate, and a US$1.2 million award, established in 2004 by Run Run Shaw. The laureates' partnership between hospitals in Paris and Shanghai spanned more than 30 years.

The players

Shaw Prize

An international award established in 2004 by Run Run Shaw that recognises outstanding achievements in science and medicine.

Zhu Chen

A professor at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, and a 2026 Shaw Prize laureate.

Anne Dejean

Professor emerita at the Institut Pasteur in Paris and a 2026 Shaw Prize laureate.

Hugues de The

Professor and chair of cellular and molecular oncology at the College de France and Hospital Saint Louis in Paris, and a 2026 Shaw Prize laureate.

The details

The ceremony took place on Tuesday, November 10, 2026, and Chief Executive John Lee Ka-chiu attended. The APL research was built on continuous cooperation between French and Chinese scientists, with Dejean's first visit to Shanghai more than 40 years ago.

Timeline

  1. 2004: The Shaw Prize was established by Run Run Shaw.

  2. Tuesday, November 10, 2026: The awards ceremony was held in Hong Kong.

Culture Shift

The award reflects a broader international shift toward cross-border scientific collaboration in medicine, following the Shaw Prize's establishment in 2004. Recognition of a multinational team also highlights how East-West partnerships are increasingly central to cancer research.

The recognition brings attention to a therapy that greatly reduced APL mortality, a cancer that affects patients worldwide. Readers interested in medical advances can follow how targeted treatments move from research into clinical use.

The takeaway

Sustained cooperation between research institutions across continents can yield treatments that change patient outcomes. The Shaw Prize's recognition of this work shows how long-term collaboration is rewarded at the highest level of scientific honour.

Further reading

Explore more Awards coverage to see how other prizes recognise scientific and cultural achievement.